Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. What Do Sugar, Gila Monsters, and the Therapeutic Dance Have in Common With GLP-1RA, Stroke, and Dementia? 2026-09-25
  2. Myo-inositol as a spectroscopic marker of neuroinflammation in frontotemporal lobar degeneration 2026-09-20
  3. Laromestrocel preserves brain volume and cognitive function in Alzheimers disease by inhibiting neuroinflammation 2026-09-17

Studies

1,157 studies carry this tag.

Date range

1986 to 2026

Top journals

  • The Journal of biological chemistry 109
  • The Journal of neuroscience : the official journal of the Society for Neuroscience 42
  • Proceedings of the National Academy of Sciences of the United States of America 39
  • Neuron 28
  • Nature 23

363 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. The American journal of pathology 2005-08-01 Inflammation and the immune system

    Cerebral vascular amyloid beta-protein (Abeta) deposition, also known as cerebral amyloid angiopathy, is a common pathological feature of Alzheimer's disease.

  2. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Nature genetics 2005-07-24 Lewy body dementia

    We have previously reported a large Danish pedigree with autosomal dominant frontotemporal dementia (FTD) linked to chromosome 3 (FTD3).

  3. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Gene 2005-06-01 Inflammation and the immune system

    We presently describe the full-length cloning and functional characterization of an HIV-1-inducible gene, astrocyte elevated gene (AEG)-1.

  4. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Neuron 2005-06-01 Lewy body dementia

    Abnormal folding of alpha-synuclein (alpha-syn) is thought to lead to neurodegeneration and the characteristic symptoms of Lewy body disease (LBD).

  5. Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The Journal of biological chemistry 2005-05-27 Risk genes beyond APOE

    Alzheimer disease is associated with extracellular deposits of amyloid beta-peptides in the brain.

  6. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. The Journal of biological chemistry 2005-05-11 Genetics

    Apolipoprotein E (apoE), a chaperone for the amyloid beta (Abeta) peptide, regulates the deposition and structure of Abeta that deposits in the brain in Alzheimer disease (AD).

  7. beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. The Journal of biological chemistry 2005-04-11 Risk genes beyond APOE

    Sequential processing of amyloid precursor protein (APP) by membrane-bound proteases, BACE1 and gamma-secretase, plays a crucial role in the pathogenesis of Alzheimer disease.

  8. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. The Journal of biological chemistry 2005-04-06 Inflammation and the immune system

    In most neurodegenerative disorders, including multiple sclerosis, Parkinson disease, and Alzheimer disease, a massive neuronal cell death occurs as a consequence of an uncontrolled inflammatory response, where activated astrocytes and microglia and their cytotoxic agents play a crucial pathological role.

  9. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Nature medicine 2005-03-20 Brain tissue and pathology

    Expression of somatostatin in the brain declines during aging in various mammals including apes and humans.

  10. P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The Journal of biological chemistry 2005-03-18 Risk genes beyond APOE

    The amyloid precursor protein (APP) is proteolytically processed by beta- and gamma-secretases to release amyloid beta, the main component in senile plaques found in the brains of patients with Alzheimer disease.

  11. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. The Journal of biological chemistry 2005-03-04 Risk genes beyond APOE

    BACE is a transmembrane protease with beta-secretase activity that cleaves the amyloid precursor protein (APP).

  12. BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The Journal of biological chemistry 2005-02-18 Risk genes beyond APOE

    The amyloidogenic pathway leading to the production and deposition of Abeta peptides, major constituents of Alzheimer disease senile plaques, is linked to neuronal metal homeostasis.

  13. Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. The Journal of biological chemistry 2005-02-17 Risk genes beyond APOE

    The use of statins, 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors that block the synthesis of mevalonate (and downstream products such as cholesterol and nonsterol isoprenoids), as a therapy for Alzheimer disease is currently the subject of intense debate.

  14. Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. The Journal of biological chemistry 2005-02-11 Risk genes beyond APOE

    gamma-Secretase, which is responsible for the intramembranous cleavage of Alzheimer beta-amyloid precursor protein and the signaling receptor Notch, is a multiprotein complex consisting of at least four components: presenilin (PS); nicastrin (Nct); APH-1 (anterior pharynx-defective-1); and presenilin enhancer-2 (PEN-2).

  15. Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. The Journal of clinical investigation 2005-02-01 Brain scans and imaging

    Neuritic plaques are a defining feature of Alzheimer disease (AD) pathology.

  16. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Brain research. Brain research reviews 2005-02-01 Inflammation and the immune system

    Chemokines were originally described as chemotactic cytokines involved in leukocyte trafficking.

  17. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. The Journal of experimental medicine 2005-02-01 TREM2 and immune genetics

    Elimination of apoptotic neurons without inflammation is crucial for brain tissue homeostasis, but the molecular mechanism has not been firmly established.

  18. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Experimental neurology 2005-02-01 Prevention and risk

    Epidemiological and experimental studies have suggested that high dietary intake of fats is associated with cognitive decline and a significantly increased risk of dementia.

  19. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2005-02-01 Lewy body dementia

    It is widely accepted that the familial Parkinson's disease (PD)-linked gene product, parkin, functions as a ubiquitin ligase involved in protein turnover via the ubiquitin-proteasome system.

  20. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. The Journal of biological chemistry 2005-01-07 Inflammation and the immune system

    Recent studies suggest that excitotoxicity may contribute to neuronal damage in neurodegenerative diseases including Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis.

  21. Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of neuroscience research 2005-01-01 Risk genes beyond APOE

    Mitochondria are involved directly in cell survival and death.

  22. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Molecular and cellular neurosciences 2005-01-01 Risk genes beyond APOE

    Few diseases are characterized by high homocysteine (HCY) and low folate and vitamin B12 blood levels.

  23. Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Proceedings of the National Academy of Sciences of the United States of America 2004-12-23 Disease mechanisms

    Transgenic Tg(PG14) mice express a mutant prion protein containing 14 octapeptide repeats, whose human homologue is associated with an inherited prion dementia.

  24. GGA proteins mediate the recycling pathway of memapsin 2 (BACE)

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. The Journal of biological chemistry 2004-12-21 Risk genes beyond APOE

    Memapsin 2 (BACE, beta-secretase) is a membrane-associated aspartic protease that initiates the hydrolysis of beta-amyloid precursor protein (APP) leading to the production of amyloid-beta (A beta) and the progression of Alzheimer disease.

  25. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of neuroinflammation 2004-12-08 Brain tissue and pathology

    Anti-Abeta immunotherapy in transgenic mice reduces both diffuse and compact amyloid deposits, improves memory function and clears early-stage phospho-tau aggregates.

  26. ApoE isoform affects LTP in human targeted replacement mice

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neuroreport 2004-12-01 Genetics

    Inheritance of the epsilon4 allele for apolipoprotein E (apoE) increases the risk of Alzheimer disease and memory impairment, whereas epsilon2 decreases these risks compared with the most common epsilon3 allele, but the mechanism for these effects is unknown.

  27. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2004-12-01 Inflammation and the immune system

    Several proteins are expressed in both immune and nervous systems.

  28. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Virology 2004-11-01 Inflammation and the immune system

    HIV-1 Nef is expressed in astrocytes, but a contribution to neuropathogenesis and the development of HIV-associated dementia (HAD) remains uncertain.

  29. Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. The Journal of biological chemistry 2004-10-13 Risk genes beyond APOE

    Gamma-secretase cleavage of beta-amyloid precursor protein (APP) is crucial in the pathogenesis of Alzheimer disease, because it is the decisive step in the formation of the C terminus of beta-amyloid protein (Abeta).

  30. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Annals of neurology 2004-10-01 Mild cognitive impairment

    Degeneration of cholinergic nucleus basalis (NB) cortical projection neurons is associated with cognitive decline in late-stage Alzheimer's disease (AD).

  31. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurochemistry 2004-10-01 Disease mechanisms

    Neurofibrillary tangles (NFTs), which are composed of hyperphosphorylated and ubiquitylated tau, are exhibited at regions where neuronal loss occurs in neurodegenerative diseases; however, the mechanisms of NFT formation remain unknown.

  32. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Stroke 2004-09-30 Inflammation and the immune system

    Accumulation of amyloid beta-peptide (Abeta) in the central nervous system (CNS) may initiate pathogenic cascades mediating neurovascular and neuronal dysfunctions associated with the development of cerebral beta-amyloidosis and cognitive decline in patients with Alzheimer disease (AD) and with related familial cerebrovascular disorders.

  33. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of neuropathology and experimental neurology 2004-09-01 Inflammation and the immune system

    Cyclooxygenase (COX) catalyses the first committed step in the synthesis of prostanoids, a large family of arachidonic acid metabolites comprising prostaglandins, prostacyclin, and thromboxanes, and is a major target of non-steroidal anti-inflammatory drugs (NSAIDs).

  34. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Nature neuroscience 2004-08-15 Brain tissue and pathology

    The E693Q mutation in the amyloid beta precursor protein (APP) leads to cerebral amyloid angiopathy (CAA), with recurrent cerebral hemorrhagic strokes and dementia.

  35. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. The Journal of clinical investigation 2004-05-01 Risk genes beyond APOE

    Alzheimer disease (AD) is characterized by excessive deposition of amyloid beta-peptides (A beta peptides) in the brain.

  36. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Science (New York, N.Y.) 2004-04-22 Lewy body dementia

    Parkin is an E3 ubiquitin ligase involved in the ubiquitination of proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD).

  37. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of neuroinflammation 2004-04-20 Inflammation and the immune system

    Roles for excitotoxicity and inflammation in Alzheimer's disease have been hypothesized.

  38. Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of neuropathology and experimental neurology 2004-04-01 Genetics

    Niemann-Pick type C1 disease (NPC1) is an autosomal recessive neurovisceral storage disease caused by the mutation of NPC1 gene, resulting in perturbed intracellular transport of unesterified cholesterol.

  39. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Nature genetics 2004-03-21 Lewy body dementia

    Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD) is a dominant progressive disorder that maps to chromosome 9p21.1-p12.

  40. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neuropharmacology 2004-03-01 Inflammation and the immune system

    The phosphodiesterase inhibitor, ibudilast, has many effects on lymphocytes, endothelial cells, and glial cells.

  41. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of biological chemistry 2004-02-24 Disease mechanisms

    Aberrant mitosis occurs in many tauopathy-related neurodegenerative diseases and is believed to precede the formation of neurofibrillary tangles.

  42. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2004-02-01 Lewy body dementia

    Cytoplasmic deposition of alpha-synuclein aggregates is a common pathological feature of many neurodegenerative diseases.

  43. Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. The Journal of biological chemistry 2004-01-06 Risk genes beyond APOE

    Inhibition of gamma-secretase, one of the enzymes responsible for the cleavage of the amyloid precursor protein (APP) to produce the pathogenic beta-amyloid (Abeta) peptides, is an attractive approach to the treatment of Alzheimer disease.

  44. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Neuroscience 2004-01-01 Risk genes beyond APOE

    Tg2576 transgenic mice (mice overexpressing the "Swedish" mutation in the human amyloid precursor protein 695) demonstrated a decreased capacity for cell proliferation in the dentate gyrus of the hippocampus compared with non-transgenic littermates at 3 months, 6 months and 9 months of age.

  45. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003-12-16 TREM2 and immune genetics

    These data show a new role for DAP12 signaling in regulating formation of multinucleated osteoclasts.

  46. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. The Journal of biological chemistry 2003-11-19 How common it is

    Lewy bodies (LBs), which are the hallmark pathologic features of Parkinson's disease and of dementia with LBs, have several morphologic and molecular similarities to aggresomes.

  47. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Proceedings of the National Academy of Sciences of the United States of America 2003-11-01 How common it is

    We here report biomagnification (the increasing accumulation of bioactive, often deleterious molecules through higher trophic levels of a food chain) of the neurotoxic nonprotein amino acid beta-methylamino-l-alanine (BMAA) in the Guam ecosystem.

  48. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Current HIV research 2003-10-01 Inflammation and the immune system

    Astrocytes are the most numerous cell type in the brain, and their physiological roles are essential for normal brain function.

  49. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Biochimica et biophysica acta 2003-10-01 Disease mechanisms

    The receptor for advanced glycation end products (RAGE) is known to be causally involved in a variety of pathophysiological processes, e.g. immune/inflammatory disorders, Alzheimer disease, tumors, and abnormalities associated with diabetes as arteriosclerosis or disordered wound healing.

  50. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2003-09-01 Disease mechanisms

    Neurodegeneration, synaptic alterations, and gliosis are prominent features of human immunodeficiency virus (HIV) encephalitis, but HIV encephalitis is distinct from other viral encephalitides because neurodegeneration occurs in uninfected neurons at anatomical sites that are often distant from the site of viral replication.

From across this tag

9 of the 1,153 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.

All topic tags with their study counts